|
π
|
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
21 auth.
E. Antonarakis,
Changxue Lu,
Hao Wang,
Brandon S. Luber,
M. Nakazawa,
J. Roeser,
Yan Chen,
Tabrez A Mohammad,
Yidong Chen,
Helen L. Fedor,
...
T. Lotan,
Qizhi Zheng,
A. D. De Marzo,
J. Isaacs,
W. Isaacs,
R. Nadal,
C. Paller,
S. Denmeade,
M. Carducci,
M. Eisenberger,
Jun Luo
|
11 |
2014 |
11
π
|
|
π¦
|
Arabidopsis LEAFY COTYLEDON1 Is Sufficient to Induce Embryo Development in Vegetative Cells
10 auth.
T. Lotan,
Masa-aki Ohto,
Kelly Yee,
M. West,
Russell Lo,
R. Kwong,
...
K. Yamagishi,
R. Fischer,
R. Goldberg,
J. Harada
|
9 |
1998 |
9
π¦
|
|
π’
|
Clinical implications of PTEN loss in prostate cancer
7 auth.
T. Jamaspishvili,
D. Berman,
A. Ross,
H. Scher,
A. M. Marzo,
J. Squire,
...
T. Lotan
|
8 |
2018 |
8
π’
|
|
π
|
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
26 auth.
C. Heaphy,
A. Subhawong,
SeungβMo Hong,
M. Goggins,
E. Montgomery,
E. Gabrielson,
G. Netto,
J. Epstein,
T. Lotan,
W. Westra,
I. Shih,
C. Iacobuzio-Donahue,
A. Maitra,
A. Maitra,
Q. K. Li,
...
C. Eberhart,
J. Taube,
D. Rakheja,
R. Kurman,
T. Wu,
R. Roden,
P. Argani,
A. Marzo,
L. Terracciano,
M. Torbenson,
A. Meeker
|
8 |
2011 |
8
π
|
|
π
|
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
9 auth.
J. Epstein,
M. Amin,
H. Beltran,
T. Lotan,
J. Mosquera,
V. Reuter,
...
B. Robinson,
P. Troncoso,
M. Rubin
|
8 |
2014 |
8
π
|
|
π¦
|
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
14 auth.
T. Lotan,
B. Gurel,
S. Sutcliffe,
David M. Esopi,
Wennuan Liu,
Jianfeng Xu,
J. Hicks,
B. Park,
E. Humphreys,
A. Partin,
...
Misop Han,
G. Netto,
W. Isaacs,
A. D. De Marzo
|
8 |
2011 |
8
π¦
|
|
π’
|
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
14 auth.
HsuehβLi Tan,
A. Sood,
Hameed A Rahimi,
W. Wang,
N. Gupta,
J. Hicks,
Stacy L. Mosier,
C. Gocke,
J. Epstein,
G. Netto,
...
Wennuan Liu,
W. Isaacs,
A. D. De Marzo,
T. Lotan
|
8 |
2013 |
8
π’
|
|
π
|
Long interspersed element-1 protein expression is a hallmark of many human cancers.
26 auth.
N. RodicΜ,
Reema Sharma,
Rajni B. Sharma,
J. Zampella,
Lixin Dai,
Martin S. Taylor,
R. Hruban,
C. Iacobuzio-Donahue,
A. Maitra,
M. Torbenson,
M. Goggins,
I. Shih,
A. Duffield,
E. Montgomery,
E. Gabrielson,
...
G. Netto,
T. Lotan,
A. D. De Marzo,
W. Westra,
Zev A. Binder,
B. Orr,
G. Gallia,
C. Eberhart,
J. Boeke,
C. Harris,
K. Burns
|
8 |
2014 |
8
π
|
|
π
|
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
27 auth.
S. Akamatsu,
A. Wyatt,
D. Lin,
Summer Lysakowski,
Fan Zhang,
Soojin Kim,
Charan Tse,
Kendric Wang,
Fan Mo,
A. Haegert,
Sonal Brahmbhatt,
R. Bell,
H. Adomat,
Y. Kawai,
Hui Xue,
...
Xin Dong,
L. Fazli,
H. Tsai,
T. Lotan,
M. Kossai,
J. Mosquera,
M. Rubin,
H. Beltran,
A. Zoubeidi,
Yuzhuo Wang,
M. Gleave,
C. Collins
|
7 |
2025 |
7
π
|
|
π
|
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
32 auth.
H. Beltran,
Andrew Hruszkewycz,
H. Scher,
Jeffrey Hildesheim,
J. Isaacs,
E. Yu,
K. Kelly,
D. Lin,
A. Dicker,
J. Arnold,
T. Hecht,
M. Wicha,
R. Sears,
D. Rowley,
R. White,
...
J. Gulley,
JohnΒ K. Lee,
Maria Diaz Meco,
E. Small,
Michael M. Shen,
K. Knudsen,
D. Goodrich,
T. Lotan,
A. Zoubeidi,
C. Sawyers,
C. Rudin,
M. Loda,
T. Thompson,
M. Rubin,
Abdul Tawab-Amiri,
W. Dahut,
P. Nelson
|
7 |
2019 |
7
π
|
|
π¦
|
ERG gene rearrangements are common in prostatic small cell carcinomas
12 auth.
T. Lotan,
N. Gupta,
W. Wang,
A. Toubaji,
Michael C. Haffner,
A. Chaux,
...
J. Hicks,
A. Meeker,
C. Bieberich,
A. Marzo,
J. Epstein,
G. Netto
|
7 |
2011 |
7
π¦
|
|
π¬
|
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation
A. Lucioni,
G. Bales,
T. Lotan,
D. McGehee,
S. Cook,
D. Rapp
|
7 |
2008 |
7
π¬
|
